Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19
Clinical trial NCT04385849 · TERMINATED
Trial details
- NCT number
- NCT04385849
- Sponsor
- ImmunityBio, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-22
- Primary completion
- 2020-07-25
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.